Cormorant Asset Management, LP - May 12, 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
10%+ Owner
Signature
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
Stock symbol
OKUR
Transactions as of
May 12, 2025
Transactions value $
-$48,236
Form type
4
Date filed
5/14/2025, 04:36 PM
Previous filing
Feb 19, 2025
Next filing
May 19, 2025
SEC
View on sec.gov

Reporting Owners (6)

Name Relationship Address Signature Signature date CIK
Cormorant Asset Management, LP 10%+ Owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member 2025-05-14 0001583977
Cormorant Global Healthcare Master Fund, LP 10%+ Owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP By: Cormorant Global Healthcare GP, LLC, its General Partner By: /s/ Bihua Chen, Managing Member 2025-05-14 0001618442
Cormorant Private Healthcare Fund III LP 10%+ Owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON CORMORANT PRIVATE HEALTHCARE FUND III, LP By: Cormorant Private Healthcare GP III, LLC, its General Partner By: /s/ Bihua Chen , Managing Member 2025-05-14 0001817320
Cormorant Private Healthcare Fund IV LP 10%+ Owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON CORMORANT PRIVATE HEALTHCARE FUND IV, LP By: Cormorant Private Healthcare GP IV, LLC, its General Partner By: /s/ Bihua Chen, Managing Member 2025-05-14 0001871297
Cormorant Private Healthcare Fund V LP 10%+ Owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON CORMORANT PRIVATE HEALTHCARE FUND V, LP By: Cormorant Private Healthcare GP V, LLC, its General Partner By: /s/ Bihua Chen, Managing Member 2025-05-14 0001969296
Chen Bihua 10%+ Owner C/O CORMORANT ASSET MANAGEMENT, LP, 200 CLARENDON STREET, 52ND FLOOR, BOSTON /s/ Bihua Chen 2025-05-14 0001599214

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV") and Cormorant Private Healthcare Fund V, LP ("Fund V"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.
F2 Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F3 Represents (i) 429,934 shares of Class A Common Stock beneficially owned by the Master Fund, (ii) 1,099,451 shares of Class A Common Stock beneficially owned by Fund III, (iii) 234,125 shares of Class A Common Stock beneficially owned by Fund IV, and (iv) 49,929 shares of Class A Common Stock beneficially owned by Fund V.